Vividion Therapeutics Stock

vividion.comHealthcare / BioTech & PharmaFounded: 2013Funding to Date: $267.82MM

Vividion Therapeutics is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets.

Register for Details

For more details on financing and valuation for Vividion Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Vividion Therapeutics.

Register Today

Team

Management Team

Trisha Millican
Chief Financial Officer
Benjamin Cravatt Ph.D
Scientific Co-Founder & Board Member
Diego Miralles MD
Chief Executive Officer & Board Member
Jin-Quan Yu Ph.D
Scientific Co-Founder
Fred Aslan MD
President & Chief Business Officer
Phil Baran Ph.D
Scientific Co-Founder

Board Members

Thomas Daniel MD
Richard Heyman Ph.D
Kristina Burow
ARCH Venture Partners
Thomas Woiwode Ph.D
Versant Venture Management
Jakob Loven Ph.D
Nextech Invest
Benjamin Cravatt Ph.D
Paul Schimmel Ph.D
John Clarke
Cardinal Partners
Diego Miralles MD

Other companies like Vividion Therapeutics in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B

News Highlights

San Diego biotech Vividion raises $82 million
Company says it's leading a resurgence of traditional small-molecule drugs
Updated on: Sep 27, 2023